angiotensin ii has been researched along with Diabetes Mellitus in 132 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 37 (28.03) | 18.7374 |
1990's | 10 (7.58) | 18.2507 |
2000's | 48 (36.36) | 29.6817 |
2010's | 24 (18.18) | 24.3611 |
2020's | 13 (9.85) | 2.80 |
Authors | Studies |
---|---|
Mosquera, J; Munoz, N; Pedreanez, A; Robalino, J; Tene, D | 1 |
Baglieri, C; Capelli, C; Casolo, A; Conti, E; Gattoni, C; Girardi, M; Jurkiewicz, A; Jurkiewicz, NH; Musial, DC; Nuccio, S; Rocha, K; Souza Bomfim, GH | 1 |
Han, P; Jensen, DM; Kriegel, AJ; Liang, M; Liu, J; Lopez-Berestein, G; Mangala, LS; Sood, AK; Usa, K; Widlansky, ME | 1 |
Capozzi, ME; Padovani-Claudio, DA; Penn, JS; Ramos, CJ | 1 |
Ferder, L; García Menéndez, S; Inserra, F; Manucha, W; Mazzei, L; Sanz, RL | 1 |
Abraham, NG; Arad, M; Aravot, D; Arow, M; Freimark, D; Hochhauser, E; Kornowski, R; Nudelman, V; Shainberg, A; Waldman, M; Yadin, D | 1 |
Boulton, ME; Grant, MB; Li Calzi, S; Obukhov, AG; Oudit, GY; Prasad, R; Raizada, MK; Stevens, BR | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Chopra, T; Draghici, S; Elahi, M; Esber, Z; Gabali, A; Hanoudi, S; Samavati, L; Sano, D; Taha, M | 1 |
Aburaya, J; Fujimoto, S; Fukuda, A; Kikuchi, M; Kitamura, K; Nagata, S; Nagatomo, M; Sato, Y | 1 |
Bers, DM; Bossuyt, J; Hegyi, B; Ko, CY | 1 |
Pawlikowski, M; Winczyk, K | 1 |
Bahreini, E; Nabi-Afjadi, M; Rezaei-Chianeh, Y | 1 |
Bader, M; Rein, J | 1 |
Scholey, JW; Williams, VR | 1 |
Guo, X; Liu, L; Liu, M; Peng, Y; Wu, XF; Yuan, JL; Yue, ZH; Zheng, XN | 1 |
Chen, L; Hao, S; Li, N; Lin, D; Ren, M; Yan, L; Yang, C; Zhu, P | 1 |
Arkun, Y; Cizmeci, D | 1 |
Abbott, GW; Anand, M; Christini, DJ; Hu, Z; Kant, R; King, EC; Krogh-Madsen, T | 1 |
Costa-Neto, CM; Duarte, DA; Lima, V; Maria, AG; Parreiras-E-Silva, LT; Prando, EC; Rodríguez, DY; Santos, GA; Souza, PP | 1 |
Bódi, N; Kovacs, G; Nyengaard, JR; Razga, Z; Talapka, P | 1 |
Jing, D; Liu, M; Liu, Y; Wang, Y; Yin, S | 1 |
Chodavarapu, H; Lazartigues, E; Pedersen, KB; Porretta, C; Robinson, LK | 1 |
James, PD; Tan, HK; Wong, F | 1 |
Campbell, DJ | 1 |
Adler, G; Baudrand, R; Garza, A; Hopkins, P; Jeunemaitre, X; Pojoga, L; Vaidya, A; Vöhringer, P; Williams, G; Williams, J; Yao, T | 1 |
Feng, C; Guo, L; Jin, H; Li, Y; Yang, X | 1 |
Bae, UJ; Cha, SA; Gao, S; Kim, SH; Park, BH; Park, BM; Park, WH | 1 |
Boas, WW; Dos Santos, RA; Nogueira, AI; Pereira, RM; Ribeiro-Oliveira, A; Simões e Silva, AC | 1 |
Arellano-Plancarte, A; Castillo-Hernandez, JR; Olivares-Reyes, JA | 1 |
Baker, KM; Kumar, R; Singh, VP | 1 |
Bagi, Z; Edes, I; Erdei, N; Feher, A; Henrion, D; Kaley, G; Koller, A; Papp, Z; Rutkai, I | 1 |
Hunyady, L | 1 |
Baker, KM; Choudhary, R; Guleria, RS; Pan, J; Tanaka, T | 1 |
Dikalov, S | 1 |
Akhtar, S; Al-Farsi, O; Benter, IF; Chandrasekhar, B; Dhaunsi, GS; Yousif, MH | 1 |
Baker, KM; Kumar, R; Thomas, CM; Yong, QC | 1 |
Bernardi, S; Burns, WC; Burrell, LM; Fabris, B; Grixti, E; Johnston, C; Pickering, R; Sakoda, M; Thomas, MC; Tikellis, C; Toffoli, B; Tsorotes, D; Velkoska, E | 1 |
Chihara, Y; Denda, A; Fujii, K; Kuniyasu, H; Luo, Y; Ohmori, H; Sasahira, T; Shimomoto, T; Tatsumoto, N | 1 |
Burns, KD; Fergusson, D; Hiremath, S; Jadhav, D; Kennedy, CR; Knoll, G; Srivaratharajah, K; Xiao, F; Zimpelmann, J | 1 |
Mehta, AA; Patel, BM | 1 |
Annes, JP; Forman, JP; Sun, B; Underwood, PC; Vaidya, A; Williams, GH; Williams, JS | 1 |
Mansoor, GA; Thavarajah, S | 1 |
Malik, RA | 1 |
Engeli, S; Gorzelniak, K; Janke, J; Luft, FC; Sharma, AM | 1 |
Gaede, P; Jensen, GV; Larsen, N; Parving, HH; Pedersen, O; Vedel, P | 1 |
Epstein, PN; Metreveli, NS; Ren, J; Ye, G | 1 |
Fisher, ND; Price, DA | 1 |
Kumar, A; McFarlane, SI; Sowers, JR | 1 |
Chen, WY; Huang, XR; Lan, HY; Truong, LD | 1 |
Brands, MW; Cloud, LJ | 1 |
Asano, T; Ogihara, T | 1 |
Ando, K | 1 |
Gaede, PH; Jensen, GV; Jepsen, PV; Larsen, JN; Parving, HH; Pedersen, OB | 1 |
Sidorenko, BA; Ugriumova, MO | 1 |
Marshall, SM | 1 |
Frohlich, ED; Sowers, JR | 1 |
Ferro, A; Hurairah, H | 1 |
Jabs, K; Kon, V | 1 |
Kohno, M | 1 |
Campbell, RC | 1 |
Mehta, JL | 1 |
Arikawa, E; Chou, E; Clermont, A; Feener, EP; He, Z; Isshiki, K; King, GL; Ma, RC; Opland, DM; Schoen, FJ; Scott, JA; Way, KJ | 1 |
Catt, KJ; Hunyady, L | 1 |
Cooper, ME; Thomas, MC; Tikellis, C | 1 |
Busse, R; Fleming, I; Kohlstedt, K | 1 |
Garaliene, V | 1 |
Nickenig, G; Ostergren, J; Struijker-Boudier, H | 1 |
Chan, CM; Lau, YK; Wong, KS; Woo, KT | 1 |
Cohn, JN | 1 |
Carvalheira, JB; Carvalho-Filho, MA; Saad, MJ; Velloso, LA | 1 |
Huang, Y; Lau, CW; Leung, FP; Lin, SG; Wong, WT; Yu, XY; Yung, LM; Zhong, JC | 1 |
de Cavanagh, EM; Ferder, L; Ferder, M; Inserra, F | 1 |
Boyle, AJ; Connelly, KA; Kelly, DJ | 1 |
Fulton, D; Marrero, MB; Stepp, D; Stern, DM | 1 |
Davis, SN; Perkins, JM | 1 |
Cardwell, RJ; Webb, RC | 1 |
Drury, PL | 1 |
Beretta-Piccoli, C; Keusch, G; Weidmann, P | 1 |
Beretta-Piccoli, C; Fraser, R; Weidmann, P | 1 |
Azukizawa, S; Hosojima, H; Kigoshi, T; Morimoto, S; Uchida, K; Yamamoto, I | 1 |
Mayes, DM; Tuck, ML | 1 |
Khristov, V; Maleeva, A; Turkolev, N | 1 |
Maezawa, H; Odakura, T; Sugiyama, H; Uchimura, I | 1 |
Cole, M; Ferriss, JB; Gonggrijp, H; O'Sullivan, DJ; Sullivan, PA | 1 |
Christlieb, AR; Gleason, RE; Rand, LI; Rhie, FH; Sandor, T; Shah, ST; Soeldner, JS | 1 |
Beretta-Piccoli, C; Weidmann, P | 1 |
Crowley, MJ; Ferriss, JB; Gonggrijp, H; O'Sullivan, DJ; Sullivan, PA | 1 |
Abe, K; Arima, S; Ito, S; Omata, K; Takeuchi, K | 1 |
Fisher, ND; Hollenberg, NK | 1 |
Brown, L; Sernia, C | 1 |
Beretta-Piccoli, C; Cusi, D; Elshater-Zanetti, F; Shaw, S; Weidmann, P | 1 |
Adams-Huet, B; Fenves, AZ; Mitchell, HC; Mulcahy, W; Smith, RD; Toto, RD | 1 |
Choi, Y; Choo, JA; Gwon, HC; Huh, JE; Kim, DK; Kim, JW; Kim, S; Lee, WR; Rhee, CH; Ryu, JC | 1 |
Weir, MR | 1 |
Carlson, SH; Shelton, J; White, CR; Wyss, JM | 1 |
Schrier, RW | 1 |
Hollenberg, NK | 1 |
Camilión de Hurtado, MC; Cingolani, HE; Pérez, NG | 1 |
Cooper, ME; de Gasparo, M; Webb, RL | 1 |
Han, HJ; Park, SH; Shin, SS | 1 |
Srivastava, AK | 1 |
Frisbee, JC; Stepp, DW | 1 |
Li, D; Mehta, JL | 1 |
Kokot, F | 1 |
Iba, K; Morii, H; Okamoto, T; Tsugawa, S; Ueno, T; Wada, M | 1 |
Cokkinos, DV; Demopoulos, JN; Gardikas, CD; Haralambakis, AG; Heimonas, ET; Thalassinos, NC; Voridis, EM | 1 |
Kim, KS; Kornel, L; Morimoto, S; Takeda, R; Uchida, K; Yamamoto, I | 1 |
Beretta-Piccoli, C; Glück, Z; Grimm, M; Keusch, G; Meier, A; Mujagic, M; Weidmann, P; Ziegler, WH | 1 |
Ferriss, JB; Gonggrijp, H; Long, AA; O'Sullivan, DJ; Sullivan, PA | 1 |
Aiello, LM; Cabral, BV; Christlieb, AR; Gleason, RE; Icasas-Cabral, EA; Janka, HU; Kraus, B; Solano, A | 1 |
Christlieb, AR | 2 |
Hems, DA | 2 |
Ahmad, MR; Ahmed, SS; Haider, B; Levinson, GE; Lyons, MM; Oldewurtel, HA; Regan, TJ | 1 |
Ikeda, T | 1 |
Donato, L | 1 |
Fujishima, M; Fujita, S; Hirakata, H; Iino, K; Ishida, I; Kashiwagi, M; Okuda, S; Yoshinari, M | 1 |
Inaba, M; Ishii, J; Itabashi, A; Katayama, S; Kawazu, S; Komeda, K; Maruno, Y; Omoto, A | 1 |
Campbell, WG; Gahnem, F; Halimi, JM; Laragh, JH; Rubattu, S; Sealey, JE; von Lutterotti, N | 1 |
Azukizawa, S; Hosojima, H; Imaizumi, N; Kigoshi, T; Morimoto, S; Uchida, K; Yamamoto, I | 1 |
Hassid, A; Kreisberg, JI | 1 |
Ikeda, M; Koshida, H; Miyamori, I; Morise, T; Nagai, K; Takeda, R; Takeda, Y; Yasuhara, S | 1 |
Hattori, N; Ikeda, T; Iwase, N; Kiyokawa, H; Noto, Y; Takata, S; Yagi, S; Yamamoto, M | 1 |
Morandini, G; Palmas, S; Piras, L | 1 |
Liebermeister, H; Schilling, WH | 1 |
Yoshida, H | 1 |
De Bono, E; Mills, IH; Wilson, RJ | 1 |
Mullane, JF | 1 |
Braaten, JT; Christlieb, AR; Munichoodappa, C | 1 |
Barontini de Moyano, MB; Hauger-Klevene, JH | 1 |
50 review(s) available for angiotensin ii and Diabetes Mellitus
Article | Year |
---|---|
Diabetes, heart damage, and angiotensin II. What is the relationship link between them? A minireview.
Topics: Angiotensin II; Diabetes Mellitus; Diabetic Cardiomyopathies; Heart; Heart Injuries; Humans; Renin-Angiotensin System | 2022 |
Elucidating glial responses to products of diabetes-associated systemic dyshomeostasis.
Topics: Angiotensin II; Diabetes Mellitus; Diabetic Retinopathy; Glucose; Humans; Hyperglycemia; Hypertension; Neuroglia; Palmitic Acid | 2023 |
Metabolic Syndrome and Cardiac Remodeling Due to Mitochondrial Oxidative Stress Involving Gliflozins and Sirtuins.
Topics: Angiotensin II; Cardiovascular Diseases; Diabetes Mellitus; Fibrosis; Humans; Hypertension; Metabolic Syndrome; Oxidative Stress; Sirtuins; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Remodeling | 2023 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Endocrine and metabolic aspects of COVID-19.
Topics: Aging; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Diabetes Mellitus; Humans; Melatonin; Obesity; Renin-Angiotensin System | 2021 |
Molecular Mechanisms Involved in Intrarenal Renin-Angiotensin and Alternative Pathways in Diabetic Nephropathy - A Review.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus; Diabetic Nephropathies; Humans; Kidney; Renin; Renin-Angiotensin System | 2021 |
Renin-Angiotensin System in Diabetes.
Topics: Angiotensin I; Angiotensin II; Animals; Diabetes Mellitus; Humans; Peptide Fragments; Renin-Angiotensin System | 2017 |
Angiotensin-converting enzyme 2 and renal disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus; Fibrosis; Humans; Inflammation; Kidney; Kidney Diseases; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2018 |
Non-canonical signalling and roles of the vasoactive peptides angiotensins and kinins.
Topics: Angiotensin II; Angiotensins; Animals; Arrestins; beta-Arrestins; Bone Resorption; Bradykinin; Central Nervous System Diseases; Diabetes Mellitus; Gene Expression Regulation; Humans; Kinins; Ligands; Neoplasms; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Signal Transduction | 2014 |
The renin-angiotensin system and diabetes: an update.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Diabetes Mellitus; Endothelium, Vascular; Humans; Hyaluronan Receptors; Insulin; Peptide Fragments; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System; Signal Transduction | 2008 |
Angiotensin II and the development of insulin resistance: implications for diabetes.
Topics: Angiotensin II; Diabetes Mellitus; Humans; Insulin Resistance; Renin-Angiotensin System | 2009 |
The intracellular renin-angiotensin system in the heart.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Fibroblasts; Humans; Hypertension; Kidney; Muscle, Smooth, Vascular; Myocytes, Cardiac; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Ventricular Remodeling | 2009 |
Cross talk between mitochondria and NADPH oxidases.
Topics: Aging; Angiotensin II; Animals; Antioxidants; Atherosclerosis; Diabetes Mellitus; Humans; Hypertension; Mice; Mitochondria; NADPH Oxidases; Neurodegenerative Diseases; Nitric Oxide Synthase Type III; Organophosphorus Compounds; Oxidation-Reduction; Oxidative Stress; Piperidines; Rabbits; Rats; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; Xanthine Oxidase | 2011 |
Intracardiac intracellular angiotensin system in diabetes.
Topics: Angiotensin II; Animals; Cricetinae; Diabetes Mellitus; Diabetic Cardiomyopathies; Disease Models, Animal; Heart; Hyperglycemia; Mice; Myocardium; Rats; Renin-Angiotensin System | 2012 |
Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases.
Topics: Aldosterone; Angiotensin II; Animals; Autocrine Communication; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus; Humans; Paracrine Communication; Renin-Angiotensin System; Signal Transduction; Water-Electrolyte Balance | 2012 |
Are clinical endpoint benefits of angiotensin converting enzyme inhibitors independent of their blood pressure effects?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Blood Pressure; Cardiovascular System; Diabetes Mellitus; Diabetic Nephropathies; Endothelium, Vascular; Humans; Hypertension; Kidney Diseases; Receptors, Angiotensin; Renin-Angiotensin System | 2002 |
The renin-angiotensin system in blacks: active, passive, or what?
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Black People; Diabetes Mellitus; Humans; Kidney; Regional Blood Flow; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary | 2003 |
Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Diabetes Complications; Diabetes Mellitus; Humans; Insulin Resistance; Kidney Failure, Chronic; Rats | 2003 |
[Hemodynamic factors].
Topics: Angiotensin II; Animals; Diabetes Mellitus; Disease Models, Animal; Humans; Hypertension; Insulin; Insulin Resistance; Oxidative Stress; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; Signal Transduction | 2003 |
[Oxidative stress].
Topics: Angiotensin II; Animals; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Humans; Hypertension; Insulin Resistance; Lipid Metabolism; Nitric Oxide; Oxidants; Oxidative Stress; Reactive Oxygen Species | 2003 |
[New perspectives of the use of angiotensin II receptor blocker].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Diabetes Mellitus; Humans; Hypertension; Hypertrophy, Left Ventricular; Hyperuricemia; Losartan; Receptors, Angiotensin | 2003 |
Insulin and insulin resistance: impact on blood pressure and cardiovascular disease.
Topics: Angiotensin II; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin; Insulin Resistance; Obesity; Risk Factors | 2004 |
The role of the endothelium in the control of vascular function.
Topics: Angiotensin II; Arteriosclerosis; Cardiovascular Diseases; Cell Adhesion Molecules; Coagulants; Diabetes Mellitus; Endothelin-1; Endothelium, Vascular; Female; Humans; Pre-Eclampsia; Pregnancy; Vasoconstrictor Agents; Vasodilator Agents | 2004 |
Angiotensin in atherosclerosis.
Topics: Angiotensin II; Arteriosclerosis; Diabetes Mellitus; Disease Progression; Estrogens; Humans; Hyperlipidemias; Hypertension; Inflammation; Insulin Resistance; Risk Factors | 2004 |
[Hypertension in patients with cardiac hypertrophy].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Complications; Diabetes Mellitus; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors | 2004 |
The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.
Topics: Angiotensin II; Atherosclerosis; Biomarkers; Coronary Artery Disease; Diabetes Mellitus; Endothelial Cells; Gene Expression Regulation; Humans; Hypertension; Lipoproteins, LDL; Myocardial Ischemia; Oxidative Stress; Predictive Value of Tests; Receptors, Oxidized LDL; Risk Factors; Scavenger Receptors, Class E; Sensitivity and Specificity; Severity of Illness Index; Signal Transduction | 2004 |
Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.
Topics: Angiotensin II; Animals; Cardiovascular Diseases; Diabetes Mellitus; Humans; Neoplasms; Receptor, Angiotensin, Type 1; Signal Transduction | 2006 |
Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fibrosis; Humans; Hyperglycemia; Hypoglycemia; Islets of Langerhans; Pancreas; Peptidyl-Dipeptidase A; PPAR gamma; Receptors, Angiotensin; Renin; Renin-Angiotensin System | 2006 |
The tissue renin-angiotensin system and intracellular signalling.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Diabetes Mellitus; Humans; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Signal Transduction | 2006 |
[The main determinants of endothelial dysfunction].
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Arteriosclerosis; Biological Availability; Diabetes Mellitus; Endothelium, Vascular; Free Radicals; Heart Failure; Homocysteine; Humans; Hypertension; Hypolipidemic Agents; Middle Aged; Models, Biological; Muscle, Smooth, Vascular; Nitric Oxide; Oxidative Stress; Potassium Channels; Reactive Oxygen Species; Renal Insufficiency; Risk Factors; Vasodilation | 2006 |
Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Cardiac Output, Low; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Humans; Hypertension; Kidney Diseases; Renin-Angiotensin System | 2006 |
[Insulin and angiotensin II signaling pathways cross-talk: implications with the association between diabetes mellitus, arterial hypertension and cardiovascular disease].
Topics: Angiotensin II; Animals; Diabetes Mellitus; Humans; Hypertension; Insulin; Insulin Resistance; MAP Kinase Signaling System; Signal Transduction; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins | 2007 |
From mitochondria to disease: role of the renin-angiotensin system.
Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Diabetes Mellitus; Humans; Hypertension; Mitochondria; Mitochondrial Diseases; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System | 2007 |
Angiotensin II and the cardiac complications of diabetes mellitus.
Topics: Angiotensin II; Animals; Diabetes Complications; Diabetes Mellitus; Heart Diseases; Humans; Up-Regulation | 2007 |
Angiotensin II-induced signaling pathways in diabetes.
Topics: Angiotensin II; Cell Division; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Glomerular Mesangium; Glycation End Products, Advanced; Humans; Hyperglycemia; Muscle, Smooth, Vascular; Reactive Oxygen Species; Signal Transduction | 2005 |
The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Diabetes Mellitus; Homeostasis; Humans; Hypertension; Insulin; Insulin Resistance; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2008 |
Diabetes and arterial hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Angiotensin II; Antihypertensive Agents; Blood Pressure; Catecholamines; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Diuretics; Female; Humans; Hypertension; Insulin; Male; Middle Aged; Obesity; Renin; Sodium; Systole; Vascular Diseases | 1983 |
Renal circulation and blockade of the renin-angiotensin system. Is angiotensin-converting enzyme inhibition the last word?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus; Humans; Kidney; Renal Circulation; Renin; Renin-Angiotensin System | 1995 |
Angiotensin receptors in cardiovascular diseases.
Topics: Acromegaly; Angiotensin II; Animals; Cardiovascular Diseases; Diabetes Mellitus; Humans; Receptors, Angiotensin; Renin-Angiotensin System; Thyroid Diseases | 1994 |
Diabetes and hypertension: blood pressure control and consequences.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diabetes Complications; Diabetes Mellitus; Humans; Hypertension; Kidney Failure, Chronic; Myocardial Contraction | 1999 |
Treating high-risk diabetic hypertensive patients with comorbid conditions.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Disease Progression; Humans; Hypertension; Kidney Failure, Chronic; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors | 2000 |
Impact of angiotensin II on the kidney: does an angiotensin II receptor blocker make sense?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Blood Volume; Clinical Trials as Topic; Diabetes Mellitus; Disease Progression; Glomerulosclerosis, Focal Segmental; Humans; Hypertension; Kidney; Peptidyl-Dipeptidase A; Proteinuria; Renin-Angiotensin System; Vasodilator Agents; Water-Electrolyte Balance | 2000 |
Angiotensin receptor blockers and the kidney: possible advantages over ACE inhibition?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus; Disease Models, Animal; Humans; Hypertension; Kidney; Kidney Diseases; Kidney Failure, Chronic; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2001 |
High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review).
Topics: Angiotensin II; Animals; Diabetes Mellitus; Diabetic Angiopathies; Enzyme Activation; Hyperglycemia; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; NF-kappa B; Protein Kinase C | 2002 |
Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor.
Topics: Angiotensin II; Coronary Artery Disease; Diabetes Mellitus; Endothelium, Vascular; Gene Expression; Humans; Myocardial Ischemia; Receptors, LDL; Receptors, Oxidized LDL; Scavenger Receptors, Class E; Tumor Necrosis Factor-alpha; Up-Regulation | 2002 |
[The renin-angiotensin-aldosterone system in diabetics].
Topics: Aldosterone; Angiotensin II; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Humans; Hypertension; Kidney; Renin | 1978 |
The greater renin system. Its prorenin-directed vasodilator limb. Relevance to diabetes mellitus, pregnancy, and hypertension.
Topics: Angiotensin II; Diabetes Mellitus; Enzyme Precursors; Female; Humans; Hypertension; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy in Diabetics; Renin; Renin-Angiotensin System; Vasoconstriction; Vasodilation | 1991 |
Functional properties of glomerular cells in culture.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Calcium; Cell Adhesion; Cells, Cultured; Contractile Proteins; Cyclic AMP; Diabetes Mellitus; Dinoprostone; Epithelial Cells; Glomerular Mesangium; Glomerulonephritis; Humans; Kidney Glomerulus; Platelet Activating Factor; Prostaglandins; Prostaglandins E; Rats | 1986 |
[Endocrinology].
Topics: 17-Ketosteroids; Adrenal Glands; Adrenal Medulla; Androgens; Angiotensin II; Diabetes Mellitus; Diabetic Nephropathies; Endocrine Glands; Estrogens; Growth Hormone; Humans; Insulin; Insulin Secretion; Lipid Metabolism; Prostaglandins; Renin; Thyroxine-Binding Proteins | 1969 |
Diabetes and hypertensive vascular disease. Mechanisms and treatment.
Topics: Alloxan; Angiotensin II; Animals; Blood Volume; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Hypertension; Hypertension, Renal; Juxtaglomerular Apparatus; Nephrosclerosis; Rats; Renin; Sympathetic Nervous System | 1973 |
6 trial(s) available for angiotensin ii and Diabetes Mellitus
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
Topics: Amputation, Surgical; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Exercise; Female; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Obesity; Risk Factors; Smoking Cessation; Stroke; Vitamins | 2003 |
[The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes].
Topics: Amputation, Surgical; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Exercise; Female; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Obesity; Risk Factors; Smoking Cessation; Stroke; Vitamins | 2003 |
Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Cross-Over Studies; Diabetes Mellitus; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Proteinuria; Ramipril; Renal Plasma Flow | 1996 |
Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects.
Topics: Angiotensin II; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus; Diabetic Retinopathy; Dose-Response Relationship, Drug; Humans; Norepinephrine; Renin | 1976 |
Effects of a new calcium antagonist, manidipine, on the renal hemodynamics and the vasoactive humoral factors in patients with diabetes mellitus.
Topics: Adult; Angiotensin II; Atrial Natriuretic Factor; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Complications; Diabetes Mellitus; Dihydropyridines; Endothelins; Female; Humans; Hypertension; Male; Middle Aged; Nitrobenzenes; Piperazines; Renal Circulation | 1992 |
77 other study(ies) available for angiotensin ii and Diabetes Mellitus
Article | Year |
---|---|
Topics: Adult; Angiotensin II; Animals; Athletic Performance; Blood Pressure; COVID-19; Diabetes Mellitus; Humans; Hypertension; Isoproterenol; Male; Muscle Fatigue; Nitric Oxide; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Receptors, Adrenergic; Running; Soccer; Streptozocin; Wine; Young Adult | 2022 |
Broad-acting therapeutic effects of miR-29b-chitosan on hypertension and diabetic complications.
Topics: Angiotensin II; Animals; Chitosan; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Fibrosis; Humans; Hypertension; Mice; Mice, Inbred Strains; Mice, Knockout, ApoE; MicroRNAs; Thiolester Hydrolases | 2022 |
Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
Topics: Angiotensin II; Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Calcium Channels, L-Type; Calcium Signaling; Cells, Cultured; Diabetes Mellitus; Diabetic Cardiomyopathies; Disease Models, Animal; Fibrosis; Glucosides; Inflammation Mediators; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Rats, Sprague-Dawley; Sodium-Calcium Exchanger; Sodium-Glucose Transporter 2 Inhibitors; Sodium-Hydrogen Exchanger 1; Ventricular Function, Left | 2020 |
SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Betacoronavirus; Bone Marrow; Coronavirus Infections; COVID-19; Diabetes Mellitus; Humans; Intestinal Mucosa; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; SARS-CoV-2; Severity of Illness Index | 2020 |
Platelets and renal failure in the SARS-CoV-2 syndrome.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin-Converting Enzyme 2; Blood Platelets; Comorbidity; COVID-19; Diabetes Mellitus; Female; Fibrin Fibrinogen Degradation Products; Glomerular Filtration Rate; Humans; Hypertension; Male; Mean Platelet Volume; Middle Aged; Pandemics; Receptors, Virus; Renin-Angiotensin System; SARS-CoV-2; Thrombocytopenia; Thrombophilia; Young Adult | 2021 |
Development of a novel AlphaLISA ImmunoAssay for Big angiotensin-25.
Topics: Adult; Angiotensin II; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged | 2021 |
Two-hit mechanism of cardiac arrhythmias in diabetic hyperglycaemia: reduced repolarization reserve, neurohormonal stimulation, and heart failure exacerbate susceptibility.
Topics: Action Potentials; Angiotensin II; Animals; Arrhythmias, Cardiac; Blood Glucose; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Diabetes Mellitus; Disease Models, Animal; Heart Conduction System; Heart Failure; Heart Rate; Isoproterenol; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Potassium Channels; Rabbits; Ryanodine Receptor Calcium Release Channel | 2021 |
[Effect of Point-moxibustion and Electroacupuncture on the Expression of Endothelial Nitric Oxide Synthase mRNA and Angiotensin 2 mRNA in Gastric Antrum in Diabetic Gastroparesis Rats].
Topics: Acupuncture Points; Angiotensin II; Animals; Diabetes Mellitus; Electroacupuncture; Gastrointestinal Motility; Gastroparesis; Moxibustion; Nitric Oxide Synthase Type III; Pyloric Antrum; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2017 |
Angiotensin II regulates collagen metabolism through modulating tissue inhibitor of metalloproteinase-1 in diabetic skin tissues.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cells, Cultured; Collagen; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Male; Matrix Metalloproteinase 1; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Skin; Tissue Inhibitor of Metalloproteinase-1 | 2013 |
Regulatory networks and complex interactions between the insulin and angiotensin II signalling systems: models and implications for hypertension and diabetes.
Topics: Angiotensin II; Diabetes Mellitus; Feedback, Physiological; Humans; Hypertension; Insulin; Models, Biological; Receptor Cross-Talk; Renin-Angiotensin System; Signal Transduction; Vasodilation | 2013 |
Kcne2 deletion creates a multisystem syndrome predisposing to sudden cardiac death.
Topics: Anemia; Angiotensin II; Angiotensinogen; Animals; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Diabetes Mellitus; Dyslipidemias; Gene Regulatory Networks; Genotype; Heterozygote; Hyperkalemia; Ischemia; Long QT Syndrome; Mice; Mice, Knockout; Potassium Channels, Voltage-Gated | 2014 |
Heterogeneous downregulation of angiotensin II AT1-A and AT1-B receptors in arterioles in STZ-induced diabetic rat kidneys.
Topics: Angiotensin II; Animals; Arterioles; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Kidney; Myocytes, Smooth Muscle; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin | 2014 |
Overexpression of angiotensin II type 2 receptor promotes apoptosis and impairs insulin secretion in rat insulinoma cells.
Topics: Angiotensin II; Animals; Apoptosis; Diabetes Mellitus; Gene Expression Regulation; Humans; Insulin; Insulin Secretion; Insulinoma; Rats; Receptor, Angiotensin, Type 2; Signal Transduction | 2015 |
Dynamics of ADAM17-Mediated Shedding of ACE2 Applied to Pancreatic Islets of Male db/db Mice.
Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cell Line, Tumor; Cell Membrane; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Progression; Insulin-Secreting Cells; Insulinoma; Islets of Langerhans; Male; Mice; Pancreatic Neoplasms; Peptidyl-Dipeptidase A; Rats; RNA, Messenger | 2015 |
Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
Topics: Administration, Intravenous; Aged; Albumins; Aldosterone; Angiotensin II; Ascites; Cardiovascular Diseases; Diabetes Mellitus; Female; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Norepinephrine; Odds Ratio; Paracentesis; Pilot Projects; Portasystemic Shunt, Transjugular Intrahepatic; Renin; Risk Factors | 2016 |
Letter by Campbell Regarding Article, "Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects".
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Diabetes Mellitus; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Renin | 2016 |
Response to Letter Regarding Article, "Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects".
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Diabetes Mellitus; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Renin | 2016 |
[In vivo study of the renoprotective effects of EGCG in diabetic db/db mice].
Topics: Angiotensin II; Animals; Catechin; Diabetes Mellitus; Kidney; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 3; NADPH Oxidases; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Proteinuria; Proto-Oncogene Proteins c-akt | 2016 |
Oxidative stress increases the risk of pancreatic β cell damage in chronic renal hypertensive rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Deoxyguanosine; Diabetes Mellitus; Hypertension; Insulin; Insulin Secretion; Insulin-Secreting Cells; Kidney; Male; Models, Animal; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Pancreas; Rats; Rats, Sprague-Dawley; Thioctic Acid | 2016 |
Activation of prostaglandin E2 EP1 receptor increases arteriolar tone and blood pressure in mice with type 2 diabetes.
Topics: Angiotensin II; Animals; Arterioles; Blood Pressure; Diabetes Mellitus; Dinoprostone; Disease Models, Animal; Hypertension; Male; Mice; Mice, Mutant Strains; Muscle, Skeletal; Prostaglandin Antagonists; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Vascular Resistance; Vasoconstrictor Agents; Xanthones | 2009 |
Physiological and pathological actions of the renin-angiotensin system.
Topics: Angiotensin II; Diabetes Mellitus; Humans; Neoplasms; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2009 |
Retinoic acid receptor-mediated signaling protects cardiomyocytes from hyperglycemia induced apoptosis: role of the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Apoptosis; Blood Glucose; Cells, Cultured; Diabetes Mellitus; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hyperglycemia; Hypoglycemic Agents; Male; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rats, Zucker; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Retinoic Acid; Renin-Angiotensin System; Retinoic Acid Receptor alpha; Retinoid X Receptor alpha; RNA Interference; RNA, Messenger; Signal Transduction; Time Factors; Tretinoin | 2011 |
Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.
Topics: Angiotensin I; Angiotensin II; Animals; Body Weight; Diabetes Mellitus; ErbB Receptors; Glucose; Hyperglycemia; Male; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Quinazolines; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; src-Family Kinases; Transcriptional Activation; Tyrphostins | 2012 |
Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Atrial Natriuretic Factor; Diabetes Mellitus; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Random Allocation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Renin-Angiotensin System | 2012 |
Diabetes-associated angiotensin activation enhances liver metastasis of colon cancer.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chymases; Colonic Neoplasms; Diabetes Complications; Diabetes Mellitus; Glucose; Glycated Hemoglobin; HT29 Cells; Humans; Hyperglycemia; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Oligoribonucleotides, Antisense; Receptor, Angiotensin, Type 1; Renin; RNA Interference; RNA, Small Interfering | 2012 |
Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme 2; Diabetes Mellitus; Female; Humans; Kidney; Kidney Transplantation; Male; Middle Aged; Peptidyl-Dipeptidase A; Renin-Angiotensin System; RNA, Messenger; Sex Factors | 2012 |
The influence of sodium- and calcium-regulatory hormone interventions on adipocytokines in obesity and diabetes.
Topics: Adipokines; Adult; Aged; Angiotensin II; Arterial Pressure; Biomarkers; Calcium; Cholecalciferol; Diabetes Mellitus; Female; Glycated Hemoglobin; Hormones; Humans; Inflammation; Infusions, Intravenous; Male; Middle Aged; Obesity; Renin-Angiotensin System; Resistin; Sodium; Young Adult | 2013 |
No morbidity-mortality. Commentary.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Atenolol; Diabetes Complications; Diabetes Mellitus; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Middle Aged; Morbidity; Patient Selection | 2002 |
Angiotensin blockade prevents type 2 diabetes by formation of fat cells.
Topics: Adipocytes; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cell Differentiation; Clinical Trials as Topic; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Hypoglycemic Agents; Insulin Resistance; Obesity; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Telmisartan | 2002 |
Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Diabetes Complications; Diabetes Mellitus; Enzyme Inhibitors; Gene Expression; Glucose; Losartan; Metallothionein; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; NADPH Oxidases; Onium Compounds; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Spectrometry, Fluorescence | 2003 |
Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease.
Topics: Adult; Aged; Angiotensin II; Cells, Cultured; Chymases; Collagen; Diabetes Mellitus; Diabetic Nephropathies; Extracellular Matrix; Glomerular Mesangium; Humans; Hypertension; Immunohistochemistry; Kidney; Kidney Tubules; Leukocytes, Mononuclear; Middle Aged; Myocytes, Smooth Muscle; Peptidyl-Dipeptidase A; Serine Endopeptidases; Up-Regulation | 2003 |
Control of arterial pressure by angiotensin II and nitric oxide at the onset of diabetes.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Enalapril; Hypertension; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 2003 |
Inhibition of the renin-angiotensin system: added value in reducing cardiovascular and renal risk?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Renal Insufficiency; Renin-Angiotensin System; Risk Factors | 2004 |
The renin-angiotensin system: a 21st century perspective.
Topics: Angiotensin II; Animals; Diabetes Mellitus; Disease Models, Animal; Humans; NG-Nitroarginine Methyl Ester; Reactive Oxygen Species; Renin; Renin-Angiotensin System | 2004 |
Differential regulation of angiotensin II-induced expression of connective tissue growth factor by protein kinase C isoforms in the myocardium.
Topics: Angiotensin II; Animals; Cells, Cultured; Connective Tissue Growth Factor; Diabetes Mellitus; Gene Expression Regulation; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Isoenzymes; Mice; Myocardium; Myocytes, Cardiac; Protein Kinase C; Rats | 2005 |
ACE inhibitor use and the long-term risk of renal failure in diabetics.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chi-Square Distribution; Diabetes Mellitus; Diabetic Nephropathies; Disease Progression; Follow-Up Studies; Humans; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Tretinoin | 2006 |
What is the role of angiotensin-receptor blockade in cardiovascular protection?
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Endothelium, Vascular; Humans; Kidney Diseases; Pilot Projects; Renin-Angiotensin System; Research Design; Vascular Diseases; Ventricular Remodeling | 2006 |
The novel peptide apelin regulates intrarenal artery tone in diabetic mice.
Topics: Acetylcholine; Adipokines; Angiotensin II; Animals; Apelin; Apelin Receptors; Blotting, Western; Carrier Proteins; Diabetes Mellitus; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Nitric Oxide Synthase Type III; Receptors, G-Protein-Coupled; Renal Artery; Vasodilation | 2007 |
Diabetes and reactivity of isolated human saphenous vein.
Topics: Aged; Angiotensin II; Blood Vessels; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Norepinephrine; Phentolamine; Potassium Chloride; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Saphenous Vein; Serotonin; Vasoconstrictor Agents | 1984 |
Responsiveness of plasma renin and aldosterone in diabetes mellitus.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Diabetes Mellitus; Female; Furosemide; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; Posture; Renin; Renin-Angiotensin System | 1981 |
Responsiveness of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II or corticotropin in nonazotemic diabetes mellitus.
Topics: 18-Hydroxycorticosterone; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Angiotensin II; Corticosterone; Diabetes Mellitus; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Uremia | 1983 |
Responsiveness of plasma aldosterone to angiotensin II in patients with diabetes mellitus.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Diabetes Mellitus; Female; Furosemide; Humans; Hydrocortisone; Male; Middle Aged; Potassium; Renin; Sodium | 1983 |
Mineralocorticoid biosynthesis in patients with hyporeninemic hypoaldosteronism.
Topics: Adrenal Insufficiency; Aged; Aldosterone; Angiotensin II; Blood Pressure; Diabetes Complications; Diabetes Mellitus; Electrolytes; Humans; Hydrocortisone; Male; Middle Aged; Mineralocorticoids; Posture; Renin | 1980 |
[Renin-angiotensin-aldosterone system in diabetes, arterial hypertension and orthostatic hypotension].
Topics: Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Diabetes Mellitus; Female; Humans; Hypertension; Hypotension, Orthostatic; Male; Middle Aged; Pulse; Renin; Urine | 1980 |
Plasma renin and aldosterone in adult-onset diabetics with persistent proteinuria.
Topics: Aldosterone; Angiotensin II; Bed Rest; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Female; Furosemide; Humans; Male; Middle Aged; Proteinuria; Renin; Renin-Angiotensin System | 1981 |
Plasma angiotensin II and aldosterone in unselected diabetic patients.
Topics: Adolescent; Adult; Age Factors; Aged; Aldosterone; Angiotensin II; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Potassium; Sex Factors; Sodium | 1982 |
Retinal vascular reactivity to norepinephrine and angiotensin II in normals and diabetics.
Topics: Adult; Angiotensin II; Diabetes Mellitus; Diabetic Retinopathy; Female; Humans; Male; Norepinephrine; Retinal Artery; Vasoconstriction | 1982 |
Exaggerated pressor responsiveness to norepinephrine in nonazotemic diabetes mellitus.
Topics: Adult; Angiotensin II; Blood Pressure; Diabetes Mellitus; Diabetic Angiopathies; Female; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Pressoreceptors | 1981 |
Plasma angiotensin II and the control of diabetes mellitus.
Topics: Adolescent; Adult; Aged; Angiotensin II; Blood Glucose; Diabetes Mellitus; Female; Hematocrit; Humans; Male; Middle Aged; Potassium; Sodium | 1980 |
High glucose augments angiotensin II action by inhibiting NO synthesis in in vitro microperfused rabbit afferent arterioles.
Topics: Acetylcholine; Angiotensin II; Animals; Arginine; Arterioles; Diabetes Mellitus; Glucose; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Perfusion; Rabbits; Vasodilation | 1995 |
Acute sodium loading in patients with uncomplicated diabetes mellitus: renal and hormonal effects.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Norepinephrine; Peptides; Renin; Renin-Angiotensin System; Sodium | 1994 |
Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1.
Topics: Alleles; Angiotensin II; Asian People; Comorbidity; Coronary Disease; Diabetes Mellitus; Ethnicity; Female; Genetic Variation; Genotype; Humans; Hypercholesterolemia; Hypertension; Korea; Male; Mass Screening; Middle Aged; Obesity; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Postmenopause; Risk Factors; Sequence Deletion; Sex Characteristics; Smoking | 1997 |
Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Carotid Arteries; Circadian Rhythm; Diabetes Mellitus; Diabetes Mellitus, Type 2; Ganglionic Blockers; Heart Rate; Hexamethonium; Hypertension; Losartan; Male; Obesity; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sodium Chloride, Dietary; Sympathetic Nervous System; Vasoconstriction | 2000 |
[What is Na+/H+ exchanger guilty of in cardiology?].
Topics: Acidosis; Angiotensin II; Animals; Bicarbonates; Calcium; Carbon Dioxide; Cell Membrane Permeability; Diabetes Mellitus; Endothelins; HEPES; Humans; Hydrogen-Ion Concentration; Hypertension; Hypertrophy, Left Ventricular; Myocardial Contraction; Myocardial Reperfusion; Myocardium; Protons; Sodium Channels; Sodium-Hydrogen Exchangers | 2000 |
High glucose levels alter angiotensin II-induced Ca(2+) uptake via PKC and cAMP pathways in renal proximal tubular cells.
Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; Culture Media, Serum-Free; Cyclic AMP; Diabetes Mellitus; Dose-Response Relationship, Drug; Down-Regulation; Glucose; Ion Transport; Kidney Tubules, Proximal; Protein Kinase C; Rabbits; Receptors, Angiotensin; Second Messenger Systems | 2001 |
Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats.
Topics: Angiotensin II; Animals; Arteries; Arterioles; Blood Pressure; Diabetes Mellitus; Endothelins; Heart Rate; Hypertension; Male; Microcirculation; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Obesity; Phentolamine; Propranolol; Rats; Rats, Zucker; Thinness; Vasoconstriction | 2002 |
The response of plasma renin activity by oral calcium loading in normal subjects and hypertensive and diabetic patients.
Topics: Administration, Oral; Adult; Aldosterone; Angiotensin II; Calcium; Diabetes Complications; Diabetes Mellitus; Female; Humans; Hypertension; Male; Renin | 1979 |
Effect of digitalis on diminished baroreceptor sensitivity in diabetics.
Topics: Adolescent; Adult; Aged; Angiotensin II; Blood Pressure; Deslanoside; Diabetes Mellitus; Digitalis Glycosides; Female; Heart Rate; Humans; Male; Middle Aged; Pressoreceptors | 1979 |
Selective hypoaldosteronism with hyperreninemia in a diabetic patient.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Corticosterone; Desoxycorticosterone; Diabetes Mellitus; Female; Humans; Hydrocortisone; Middle Aged; Potassium; Renin; Sodium | 1979 |
Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus.
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Blood Volume; Chlorthalidone; Diabetes Complications; Diabetes Mellitus; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Placebos; Sodium | 1979 |
Hypertension, hyperkalaemia and abnormalities of the renin-angiotensin system in diabetes mellitus.
Topics: Angiotensin I; Angiotensin II; Angiotensins; Diabetes Complications; Diabetes Mellitus; Glucose Tolerance Test; Humans; Hyperkalemia; Hypertension; Middle Aged; Potassium; Renin | 1979 |
Renin-angiotensin-aldosterone system in diabetes mellitus.
Topics: Aldosterone; Angiotensin II; Animals; Blood Volume; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Ketoacidosis; Diabetic Nephropathies; Diabetic Neuropathies; Humans; Hypertension; Hypotension, Orthostatic; Juxtaglomerular Apparatus; Models, Biological; Potassium; Rats; Renin; Sodium; Vascular Resistance; Water-Electrolyte Balance | 1976 |
Short-term hormonal control of hepatic carbohydrate and lipid catabolism.
Topics: Angiotensin II; Animals; Diabetes Mellitus; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerides; Hormones; Insulin; Liver; Liver Glycogen; Nucleotides, Cyclic; Obesity; Oxytocin; Parathyroid Hormone; Protein Kinases; Starvation; Stress, Physiological; Vasopressins | 1977 |
Evidence for cardiomyopathy in familial diabetes mellitus.
Topics: Adult; Aged; Angiocardiography; Angiotensin II; Collagen; Coronary Vessels; Diabetes Complications; Diabetes Mellitus; Female; Heart Diseases; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Phospholipids; Triglycerides | 1977 |
Short-term hormonal control of fat metabolism in the liver [proceedings].
Topics: Acyl Coenzyme A; Angiotensin II; Animals; Diabetes Mellitus; Epinephrine; Fatty Acids; Hormones; Lipid Metabolism; Liver; Mice; Obesity | 1977 |
[The renin-angiotensin system in diabetes mellitus (author's transl)].
Topics: Adolescent; Adult; Aged; Angiotensin II; Diabetes Mellitus; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Renin | 1977 |
[Significance of radioimmunological determination as a tool for clinical research].
Topics: Angiotensin II; Diabetes Mellitus; Growth Hormone; Humans; Hypertension; Insulin; Radioimmunoassay; Research | 1975 |
Hyperreninemia due to increased renal renin synthesis in BioBreeding Worcester rats.
Topics: Angiotensin II; Animals; Diabetes Mellitus; Disease Susceptibility; Hypertension; Immunohistochemistry; Kidney; Rats; Rats, Inbred BB; Rats, Inbred Strains; Renin; RNA, Messenger; Staining and Labeling | 1990 |
Unresponsiveness of plasma mineralocorticoids to angiotensin II in diabetic patients with asymptomatic normoreninemic hypoaldosteronism.
Topics: 18-Hydroxycorticosterone; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Corticosterone; Desoxycorticosterone; Diabetes Mellitus; Female; Humans; Hydrocortisone; Infusions, Parenteral; Injections, Intramuscular; Male; Middle Aged; Renin | 1985 |
Effect of metoclopramide on orthostatic hypotension in diabetes mellitus: failure to demonstrate the role of vasoconstrictive hormones.
Topics: Administration, Oral; Adult; Aldosterone; Angiotensin II; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Humans; Hypotension, Orthostatic; Male; Metoclopramide; Middle Aged; Norepinephrine; Renin; Vasoconstrictor Agents | 1988 |
Effects of insulin on pressor responsiveness and baroreflex function in diabetes mellitus.
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Diabetes Mellitus; Female; Humans; Insulin; Male; Middle Aged; Phenylephrine; Pressoreceptors; Vasoconstriction | 1986 |
[Study on peripheral vascular reactivity to angiotensin and noradrenalin in subjects with diabetes mellitus].
Topics: Adolescent; Adult; Aged; Angiotensin II; Child; Diabetes Mellitus; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; Norepinephrine; Skin Tests | 1965 |
[Studies of the effect of synthetic angiotensin II on blood sugar levels in persons with manifest and latent diabetes mellitus].
Topics: Adult; Aged; Angiotensin II; Blood Glucose; Blood Pressure; Diabetes Mellitus; Glucose Tolerance Test; Humans; Injections, Intravenous; Middle Aged | 1967 |
Cardiovascular reflexes and the control of aldosterone production and sodium excretion.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Cardiovascular Physiological Phenomena; Diabetes Mellitus; Fludrocortisone; Humans; Hypopituitarism; Hypotension, Orthostatic; Male; Norepinephrine; Posture; Potassium; Reflex; Renin; Sodium | 1969 |
End-vessel reactivity and capillary clearance in diabetes mellitus.
Topics: Angiotensin II; Arteriosclerosis; Capillaries; Capillary Permeability; Diabetes Mellitus; Humans; Injections, Intradermal; Skin Tests; Sodium Chloride; Vasomotor System; Wound Healing | 1970 |
Decreased response of plasma renin activity to orthostasis in diabetic patients with orthostatic hypotension.
Topics: Adult; Aldosterone; Amyloidosis; Angiotensin II; Animals; Blood Pressure; Cattle; Diabetes Complications; Diabetes Mellitus; Female; Humans; Hypertension; Hypotension, Orthostatic; Iodine Radioisotopes; Male; Middle Aged; Norepinephrine; Posture; Pulse; Rabbits; Radioimmunoassay; Renin; Tyramine | 1974 |
The renin-angiotensin system in diabetes mellitus.
Topics: Angiotensin II; Blood Pressure; Diabetes Mellitus; Epinephrine; Furosemide; Humans; Hypertension; Juxtaglomerular Apparatus; Norepinephrine; Renin; Stimulation, Chemical | 1974 |